Comparing the minimum inhibitory and mutant prevention concentrations of selected antibiotics against animal isolates of Pasteurella multocida and Salmonella typhimurium
- PMID: 35144445
- PMCID: PMC8831991
- DOI: 10.4102/ojvr.v89i1.1955
Comparing the minimum inhibitory and mutant prevention concentrations of selected antibiotics against animal isolates of Pasteurella multocida and Salmonella typhimurium
Abstract
Historically, the use of antibiotics was not well regulated in veterinary medicine. The emergence of antibiotic resistance (ABR) in pathogenic bacteria in human and veterinary medicine has driven the need for greater antibiotic stewardship. The preservation of certain antibiotic classes for use exclusively in humans, especially in cases of multidrug resistance, has highlighted the need for veterinarians to reduce its use and redefine dosage regimens of antibiotics to ensure efficacy and guard against the development of ABR pathogens. The minimum inhibitory concentration (MIC), the lowest concentration of an antibiotic drug that will prevent the growth of a bacterium, is recognised as a method to assist in antibiotic dosage determination. Minimum inhibitory concentrations sometimes fail to deal with first-step mutants in bacterial populations; therefore dosing regimens based solely on MIC can lead to the development of ABR. The mutant prevention concentration (MPC) is the minimum inhibitory antibiotic concentration of the most resistant first-step mutant. Mutant prevention concentration determination as a complementary and sometimes preferable alternative to MIC determination for veterinarians when managing bacterial pathogens. The results of this study focused on livestock pathogens and antibiotics used to treat them, which had a MIC value of 0.25 µg/mL for enrofloxacin against all 27 isolates of Salmonella typhimurium. The MPC values were 0.50 µg/mL, with the exception of five isolates that had MPC values of 4.00 µg/mL. The MPC test yielded 65.52% (18 isolates) Salmonella isolates with florfenicol MICs in the sensitive range, while 11 isolates were in the resistant range. Seventeen isolates (58.62%) of Pasteurella multocida had MIC values in the susceptible range and 41.38% (12 isolates) had an intermediate MIC value. Mutant prevention concentration determinations as done in this study is effective for the antibiotic treatment of bacterial infections and minimising the development of resistance. The MPC method can be used to better control to prevent the development of antibiotic drug resistance used in animals.
Keywords: MIC; MPC; Pasteurella; Salmonella; animals; minimum inhibitory concentration; mutant prevention concentration.
Conflict of interest statement
The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.
Figures
Similar articles
-
Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.PLoS One. 2019 Jan 10;14(1):e0210154. doi: 10.1371/journal.pone.0210154. eCollection 2019. PLoS One. 2019. PMID: 30629633 Free PMC article.
-
Comparison of the Minimum Inhibitory and Mutant Prevention Drug Concentrations for Pradofloxacin and 7 Other Antimicrobial Agents Tested Against Swine Isolates of Actinobacillus pleuropneumoniae and Pasteurella multocida.Molecules. 2024 Nov 19;29(22):5448. doi: 10.3390/molecules29225448. Molecules. 2024. PMID: 39598838 Free PMC article.
-
Concentration-resistance relationship and PK/PD evaluation of danofloxacin against emergence of resistant Pasteurella multocida in an in vitro dynamic model.J Appl Microbiol. 2024 Jul 2;135(7):lxae154. doi: 10.1093/jambio/lxae154. J Appl Microbiol. 2024. PMID: 38925653
-
A unified anti-mutant dosing strategy.J Antimicrob Chemother. 2008 Sep;62(3):434-6. doi: 10.1093/jac/dkn229. Epub 2008 Jun 10. J Antimicrob Chemother. 2008. PMID: 18544596 Free PMC article. Review.
-
What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review.Clin Pharmacokinet. 2019 Nov;58(11):1407-1443. doi: 10.1007/s40262-019-00791-z. Clin Pharmacokinet. 2019. PMID: 31325141
Cited by
-
Enrofloxacin-The Ruthless Killer of Eukaryotic Cells or the Last Hope in the Fight against Bacterial Infections?Int J Mol Sci. 2022 Mar 26;23(7):3648. doi: 10.3390/ijms23073648. Int J Mol Sci. 2022. PMID: 35409007 Free PMC article. Review.
-
Mutant Prevention Concentration, Frequency of Spontaneous Mutant Selection, and Mutant Selection Window-a New Approach to the In Vitro Determination of the Antimicrobial Potency of Compounds.Antimicrob Agents Chemother. 2023 May 17;67(5):e0137322. doi: 10.1128/aac.01373-22. Epub 2023 Apr 6. Antimicrob Agents Chemother. 2023. PMID: 37022162 Free PMC article.
References
-
- Blondeau, J.M., 2009b, STAT International companion animal: Steps to antimicrobial therapy, North American Compendiums, Incorporated, Port Huron, MI.
-
- Blondeau, J.M., Borsos, S., Hesje, C., Blondeau, L.D. & Blondeau, B.J., 2007, ‘Comparative minimum inhibitory concentration (MIC) and mutant prevention concentration (MPC) values of enrofloxacin, florfenicol, tilmicosin and tulathromycin against Mannheimia haemolytica (MH) isolates collected from cattle and bovine respiratory disease’, in International meeting of emerging diseases and surveillance (IMED), February 23–25, 2007, Vienna, Austria.
-
- Blondeau, J.M. & Fitch, S.D., 2019, ‘Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis’, PLoS One 14(1), e0210154. 10.1371/journal.pone.0210154 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical